	US 11,701,395 B2
	Food composition and pharmaceutical composition for inhibiting Sjogren's syndrome each containing Bifidobacterium pseudocatenulatum C-RAPO (KCTC13986BP) and Bifidobacterium bifidum ATT (KCTC13474BP)
Geun Eog Ji, Seoul (KR); and Myeong Soo Park, Seoul (KR)
Assigned to BIFIDO CO., LTD., Hongcheon-gun (KR)
Filed by BIFIDO CO., LTD., Gangwon-do (KR)
Filed on Jan. 12, 2022, as Appl. No. 17/574,399.
Application 17/574,399 is a division of application No. 16/946,658, filed on Jun. 30, 2020, granted, now 11,253,555.
Claims priority of application No. 10-2020-0033513 (KR), filed on Mar. 19, 2020.
Prior Publication US 2022/0211775 A1, Jul. 7, 2022
Int. Cl. A61K 35/745 (2015.01); A61K 39/00 (2006.01); A61K 39/05 (2006.01); A61K 35/00 (2006.01); A23L 33/00 (2016.01); A23L 33/135 (2016.01); A61P 37/02 (2006.01); A61K 9/00 (2006.01)

CPC A61K 35/745 (2013.01) [A23L 33/135 (2016.08); A23L 33/40 (2016.08); A61K 9/0056 (2013.01); A61K 39/05 (2013.01); A61P 37/02 (2018.01); A23V 2002/00 (2013.01); A23Y 2300/25 (2013.01); A23Y 2300/59 (2013.01); A61K 2035/115 (2013.01)]

4 Claims

1. A method of inhibiting sialoadenitis symptom in a subject having Sjogren's syndrome comprising administering orally to said subject a food composition comprising an effective amount of an isolated strain of Bifidobacterium bifidum ATT deposited as KCTC13474BP.